COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1917: Articles 19161-19170  | Next

Design of Specific Primer Set for Detection of B.1.1.7 SARS-CoV-2 Variant using Deep Learning
Lopez-Rincon, A., Perez-Romero, C., Tonda, A., Mendoza-Maldonado, L., Claassen, E., Garssen, J., Kraneveld, A. D.
10.1101/2020.12.29.424715 — Posted: 2020-12-29 Discussion: Onsite
SARS-CoV-2 highly conserved s2m element dimerizes via a kissing complex and interacts with host miRNA-1307-3p
Imperatore, J. A., Cunningham, C. L., Pellegrene, K. A., Brinson, R. G., Marino, J. P., Evanseck, J. D., Mihailescu, M. R.
10.1101/2020.12.29.424733 — Posted: 2020-12-29
Structural basis for broad coronavirus neutralization
Veesler, D.
10.1101/2020.12.29.424482 — Posted: 2020-12-29
Host Specific SARS-CoV-2 Mutations: Insertion of the Phenylalanine in the NSP6 Linked to the United Kingdome and Premature Termination of the ORF-8 Associated with the European and the United States of America Derived Samples.
Khalid, M., Al-ebini, Y., Murphy, D., Shoai, M.
10.1101/2020.12.29.424530 — Posted: 2020-12-29
Defective NETs Clearance contributes to sustained FXII Activation in COVID-19-associated Pulmonary Thrombo-Inflammation
Frye, M., Englert, H., Rangaswamy, C., Deppermann, C., Sperhake, J.-P., Krisp, C., Schreier, D., Gordon, E., Konrath, S., Haddad, M., Pula, G., Mailer, R., Schlueter, H., Langer, F., Pueschel, K., Panousis, K., Stavrou, E., Maas, C., Renne, T.
10.1101/2020.12.29.424644 — Posted: 2020-12-29
Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence
Bullen, G., Galson, J. D., Villar, P., Moreels, L., Ledsgaard, L., Mattiuzzo, G., Hall, G., Bentley, E. M., Masters, E. W., Tang, D., Millett, S., Tongue, D., Brown, R., Diamantopoulos, I., Parthiban, K., Tebbutt, C., Leah, R., Chaitanya, K., Pazeraitis, D., Surade, S. B., Ashiru, O., Crippa, L., Cowan, R., Bowler, M. W., Campbell, J. I., Lee, W.-Y. J., Carr, M. D., Matthews, D., Pfeffer, P., Hufton, S. E., Sawmynaden, K., Osbourn, J., McCafferty, J., Karatt-Vellatt, A.
10.1101/2020.12.29.424711 — Posted: 2020-12-29
Paired SARS CoV-2 Spike Protein Mutations Observed During Ongoing SARS-CoV-2 Viral Transfer from Humans to Minks and Back to Humans
Rubsamen, R., Burkholz, S., Pokhrel, S., Kraemer, B. R., Mochly-Rosen, D., Carback, R. T., Hodge, T., Harris, P., Ciotlos, S., Wang, L., Herst, C.
10.1101/2020.12.22.424003 — Posted: 2020-12-29
Rapid inactivation in vitro of SARS-CoV-2 in saliva by black tea and green tea
Ohgitani, E., Shin-Ya, M., Ichitani, M., Kobayashi, M., Takihara, T., Kawamoto, M., Kinugasa, H., Mazda, O.
10.1101/2020.12.28.424533 — Posted: 2020-12-28
Analysis and Forecasting of Global of RT-PCR Primers for SARS-CoV-2
Nayar, G., Seabolt, E., Kunitomi, M., Agarwal, A., Beck, K. L., Mukherjee, V., Kaufman, J.
10.1101/2020.12.26.424429 — Posted: 2020-12-28
SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity
Ramirez, C., Kumar Sharma, A., Kee, C., Thomas, L., Boulant, S., Herrmann, C.
10.1101/2020.12.28.424029 — Posted: 2020-12-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).